Subcuject Aps

Subcuject Aps is located in Hellebæk, Denmark on Nordre Strandvej 119. Subcuject Aps is rated 3 out of 5 in the category medical devices in Denmark. Subcuject is a medical device company developing and commercializing an innovative and proprietary platform for subcutaneous Wearable Bolus Injection (WBI). The device platform applies osmosis as driving force, and offers a unique combination of performance, usability and cost. Subcuject is financed by the venture funds Vaekstfonden and CAPNOVA. New biological pharmaceuticals require delivery of large and highly viscous doses. This drug delivery task requires a new type of injectors; wearable injectors. State of the art injection devices are complex and expensive, with mechanisms and electronics in order to achieve sufficient injection pressure. The Subcuject WBI platform is a cost-effective innovation: Forward osmosis technology is applied to generate injection force. In simplified terms two chambers of liquid are separated by a semipermeable membrane. Adding a salt to one chamber draws in liquid from the other chamber. Hereby hydraulic/mechanical pressure for drug injection is generated. Simple and cost-effective. The cost-effective Subcuject Platform provides a wide range of advantages: - Pre-filled and pre-loaded - Injects drugs with high viscosities - Accommodates high dose volumes - Simple activation and noiseless operation - Injection speed can be preset from fast to very slow - Adaptable to customized and standard cartridges in glass or polymer - Dimensions smaller than state of the art - Thin needle - Inserts needle at activation, and retracts needle automatically after completed injection - No electronics needed for operation Subcuject is organized as a virtual organization, applying external experts and specialist organizations. Our management team and board has decades of experience and track record in medtech, pharma and drug delivery.